
Enveric Biosciences Inc
ENVB · NASDAQ · Healthcare / Biotechnology
1.52USD-0.01 (-0.33%)
Price History
Full chartMarket Stats
Previous Close1.52
Open1.52
Day Range1.51 – 1.57
52-Week Range1.17 – 13.25
Volume17.58K
Market Cap6.92M
P/E (TTM)0.00
Forward P/E23.09
EPS-11.99
Dividend Yield0.00%
Beta1.11
50-Day Avg1.45
200-Day Avg2.46
About
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Company Details
- SectorHealthcare
- IndustryBiotechnology
- CEOMr. Kevin M. Coveney CPA
- Employees5
- Headquarters245 First Street, Cambridge, MA, United States, 02142, USA
- Websitehttps://www.enveric.com
Leadership
- Mr. Kevin M. Coveney CPAChief Financial Officer · b. 1964
- Dr. Peter J. Facchini Ph.D.Chief Innovation Officer · b. 1964
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Market Cap6.92M
Enterprise Value-1.40M
Trailing P/E0.00
Forward P/E23.09
Price / Sales0.08
Price / Book0.85
EPS-11.99
Book Value2.05
Revenue (TTM)35.41M
Gross Profit (TTM)8.15M
EBITDA-8.57M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-170.04%
Return on Assets-87.34%
Shares Outstanding4.48M
Shares Float4.34M
Beta1.11
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%
Analyst Ratings
Buy
Based on 1 analystsTarget 10.00
- Buy1
Ownership Breakdown
- Institutions
- 12.02%
- Insiders
- 8.89%
- Retail / Other
- 79.09%
Top Institutional Holders
- Sio Capital Management, LLC180.00K4.02%
- AdvisorShares Investments, LLC35.42K0.79%
- Geode Capital Management, LLC32.15K0.72%
- Citadel Advisors Llc13.96K0.31%
- UBS Group AG3.61K0.08%
- Tower Research Capital LLC1.10K0.02%
- JONES FINANCIAL COMPANIES LLLP1.00K0.02%
- Integrated Wealth Concepts LLC7020.02%
- SBI Securities Co Ltd830.00%
- BlackRock Inc510.00%
- Wells Fargo & Co10.00%
- NATIONAL BANK OF CANADA /FI/10.00%
- Danske Bank A/S.10.00%
- Group One Trading, LLC10.00%
- Citigroup Inc00.00%
- Bank of America Corp00.00%
Top Fund Holders
- AdvisorShares Psychedelics ETF42.37K0.95%
- Fidelity Extended Market Index11.55K0.26%
Stock Splits
- Oct 28, 20251:12
- Jan 29, 20251:15
- Jul 15, 20221:50
- Dec 31, 20201:4
- Nov 25, 20191:25
- May 26, 2015100:1761
- Dec 17, 20081:10